Skip to content
ReelPoint

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Agreement Over Data Fears

Health funding image
The proposed American funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years over the United States' demand for confidential information.

This move was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

A government spokesman has since explained that the United States was requesting genetic material for research and commercial purposes while was unwilling to guarantee the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further talks to find a agreement suitable to all parties so the nation's critical HIV treatment initiative can be sustained.

Wider Implications

This development comes after a comparable situation in Kenya, where a high court blocked a similar deal with the US after concerns were raised about the security of Kenyans' health data.

After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to boost openness and accountability.

According to statements, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Agreement

The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont said.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to provide its genetic material and health information over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our population should a new disease outbreak arise."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting systems previously set up via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing system designed to manage potential pandemics.

"This framework is intended to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."

These objections over the US deal "are not meant as hostility towards the US," he added.

"We encourage further discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and dignity of each country."

Health Experts Reaction

Medical experts said it understood the government's concerns, but urged that negotiations must proceed given that much of the country's HIV programmes relied on foreign aid.

"In cases where specific concerns exist, such as those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group commented.

The halted deal emphasises the ongoing tensions between receiving crucial international aid and protecting a country's data in an increasingly interconnected world.

About the author

Todd Wright

Award-winning filmmaker and industry analyst with over a decade of experience in documentary and commercial production.

ReelPoint

Type to search articles.